Colorectal cancer is a widespread clinical entity—affecting more than 1 million individuals
globally on an annual basis. 1–3 Colorectal cancer remains the third most common nonskin …

Background Testing for carcino‐embryonic antigen (CEA) in the blood is a recommended
part of follow‐up to detect recurrence of colorectal cancer following primary curative …

Follow‐up strategies for patients treated for non‐metastatic colorectal cancer - Jeffery, M - 2019
| Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Objective: To review the evidence from clinical trials of follow up of patients after curative
resection for colorectal cancer. Design: Systematic review and meta-analysis of randomised …

CEA Structure, Function, and Gene Family CEA defines a class of complex glycoproteins
that is one of approximately 20 related molecules of the immunoglobulin gene …

Guidelines for resection of colorectal cancer liver metastases | Gut Skip to main content
Viewing from: Google Indexer BMJ Journals Subscribe Log In More Log in via Institution Log …

Background & Aims: Guidelines on the type and frequency of follow-up of patients after
curative surgery for colorectal cancer are unclear. The aim of this study was to determine the …

Abstract Introduction Carcinoembryonic Antigen (CEA) has been used as a tumor marker in
the follow-up of colorectal cancer for more than 40 years. Controversy exists regarding its …

INTRODUCTION: The aim of the study was to evaluate the diagnostic precision of serum
carcinoembryonic antigen (CEA) in the detection of local or distant recurrence following …

Purpose: Because predicting recurrence intervals and patterns would allow for appropriate
therapeutic strategies, we evaluated the clinical and pathological characteristics of early and …